Form 8-K - Current report:
SEC Accession No. 0000944809-20-000004
Filing Date
2020-02-26
Accepted
2020-02-26 16:06:54
Documents
18
Period of Report
2020-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kearningsq420202x26.htm   iXBRL 8-K 56483
2 EXHIBIT 99.1 ex991-pressrelease2x26.htm EX-99.1 161228
3 EXHIBIT 99.2 ex992-pressrelease2x20.htm EX-99.2 8554
9 a022620opk4q2019frimage1.gif GRAPHIC 2888
10 opko4q19frimage1a01.gif GRAPHIC 6163
  Complete submission text file 0000944809-20-000004.txt   396847

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20200220.xsd EX-101.SCH 4594
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20200220_cal.xml EX-101.CAL 638
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20200220_def.xml EX-101.DEF 1488
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20200220_lab.xml EX-101.LAB 26142
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20200220_pre.xml EX-101.PRE 13594
17 EXTRACTED XBRL INSTANCE DOCUMENT a8-kearningsq420202x26_htm.xml XML 4320
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 20655682
SIC: 2834 Pharmaceutical Preparations